Louie D S, Chen H T, Owyang C
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor.
J Pharmacol Exp Ther. 1988 Jul;246(1):132-6.
This study evaluates the hypothesis that opiates suppress pancreatic enzyme secretion by inhibiting cholinergic transmission in the pancreas. Rat pancreatic lobules were incubated in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid-Ringer's buffer and amylase release in response to KCl depolarization of the intrapancreatic nerve in the absence or presence of specific opiate subtype receptor agonists was studied. Depolarization by 75 mM KCl resulted in a 5-fold increase in amylase output. Pretreatment with 1 microM atropine inhibited completely the KCl-stimulated amylase release, suggesting stimulation via a cholinergic pathway. Addition of methionine enkephalin or 2-D-penicillamine-5-D-penicillamine-enkephalin [( D-Pen2, D-Pen5]enkephalin, a specific delta receptor agonist) inhibited KCl-stimulated amylase release in a dose-dependent fashion. Methionine enkephalin (1 microM) or [D-Pen2, D-Pen5]enkephalin inhibited KCl-stimulated amylase release by 32 +/- 4 and 45 +/- 4%, respectively. Addition of 1 microM ICI 174,864 (a delta opiate receptor antagonist) blocked the inhibitory effect of [D-Pen2, D-Pen5]enkephalin. Upjohn 50,488H (1 microM, a specific kappa agonist) and 1 microM Tyr-D-Ala-Gly-MePhe-Gly-ol (a specific mu agonist) had no effect. Methionine enkephalin had no effect on carbachol (1 microM)-stimulated amylase release. These data suggest that methionine enkephalin acts on a delta opiate receptor located on postganglionic cholinergic neurons. To examine the ability of methionine enkephalin to alter acetylcholine release from pancreatic tissue, pancreatic lobules were incubated with [3H]choline and the release of synthesized [3H]acetylcholine was stimulated by KCl. Depolarization of the nerves with 75 mM KCl increased [3H]acetylcholine release by 35 +/- 5% over basal.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究评估了阿片类药物通过抑制胰腺中的胆碱能传递来抑制胰腺酶分泌这一假说。将大鼠胰腺小叶置于4-(2-羟乙基)-1-哌嗪乙磺酸-林格氏缓冲液中,研究在有无特定阿片类药物亚型受体激动剂的情况下,胰腺内神经经氯化钾去极化后淀粉酶的释放情况。75 mM氯化钾去极化导致淀粉酶输出增加5倍。用1 microM阿托品预处理可完全抑制氯化钾刺激的淀粉酶释放,提示通过胆碱能途径进行刺激。添加甲硫氨酸脑啡肽或2-D-青霉胺-5-D-青霉胺-脑啡肽[(D- Pen2,D- Pen5)脑啡肽,一种特异性δ受体激动剂]可剂量依赖性地抑制氯化钾刺激的淀粉酶释放。甲硫氨酸脑啡肽(1 microM)或[(D- Pen2,D- Pen5)脑啡肽分别抑制氯化钾刺激的淀粉酶释放32±4%和45±4%。添加1 microM ICI 174,864(一种δ阿片受体拮抗剂)可阻断[(D- Pen2,D- Pen5)脑啡肽的抑制作用。Upjohn 50,488H(1 microM,一种特异性κ激动剂)和1 microM Tyr-D-Ala-Gly-MePhe-Gly-ol(一种特异性μ激动剂)无作用。甲硫氨酸脑啡肽对卡巴胆碱(1 microM)刺激的淀粉酶释放无作用。这些数据表明,甲硫氨酸脑啡肽作用于节后胆碱能神经元上的δ阿片受体。为了研究甲硫氨酸脑啡肽改变胰腺组织中乙酰胆碱释放的能力,将胰腺小叶与[3H]胆碱一起孵育,并用氯化钾刺激合成的[3H]乙酰胆碱的释放。75 mM氯化钾使神经去极化,使[3H]乙酰胆碱释放量比基础值增加35±5%。(摘要截短于250字)